Klinisk Biokemi i Norden · 2 2015
| 29
an eight-year review. Chin Med J (Engl)
1997;110:936-41.
5. Backes CH, Markham K, Moorehead P, Cor-
dero L, Nankervis CA, Giannone PJ. Maternal
preeclampsia and neonatal outcomes. J Preg-
nancy 2011;2011:214365.
6. Carty DM, Delles C, Dominiczak AF. Preec-
lampsia and future maternal health. J Hyper-
tens 2010;28:1349-55.
7. Kajantie E, Eriksson JG, Osmond C, Thorn-
burg K, Barker DJ. Pre-eclampsia is associated
with increased risk of stroke in the adult off-
spring: the Helsinki birth cohort study. Stroke
2009;40:1176-80.
8. Roberge S, Villa P, Nicolaides K, Giguère Y,
Vainio M, Bakthi A, et al. Early administra-
tion of low-dose aspirin for the prevention of
preterm and term preeclampsia: a systematic
review and meta-analysis. Fetal Diagn Ther
2012;31:141-6.
9. Report of the National High Blood Pressure
Education Program Working Group on High
Blood Pressure in Pregnancy. Am J Obstet
Gynecol 2000;183:s1-s22.
10. Redman CW, Sacks GP, Sargent IL. Preec-
lampsia: an excessive maternal inflammatory
response to pregnancy. Am J Obstet Gynecol
1999;180:499-506.
11. Roberts JM. Endothelial dysfunction in
preeclampsia. Semin Reprod Endocrinol
1998;16(1):5-15.
12. Levine RJ, Maynard SE, Qian C, Lim KH, Eng-
land LJ, Yu KF, et al. Circulating angiogenic
factors and the risk of preeclampsia. N Engl J
Med 2004;350:672-83.
13. Hubel CA, McLaughlin MK, Evans RW, Hauth
BA, Sims CJ, Roberts JM. Fasting serum trigly-
cerides, free fatty acids, and malondialdehyde
are increased in preeclampsia, are positively
correlated, and decrease within 48 hours post
partum. Am J Obstet Gynecol 1996;174:975-
82.
14. Kaaja R, Laivuori H, Laakso M, Tikkanen MJ,
Ylikorkala O. Evidence of a state of increased
insulin resistance in preeclampsia. Metabo-
lism 1999;48:892-6.
15. Myatt L, Redman CW, Staff AC, Hansson
S, Wilson ML, Laivuori H, et al. Strategy
for standardization of preeclampsia research
study design. Hypertension 2014;63:1293-301.
16. Roberts JM, Bell MJ. If we know so much
about preeclampsia, why haven't we cured the
disease? J Reprod Immunol 2013;99:1-9.
17. Burton GJ, Woods AW, Jauniaux E, Kingdom
JC. Rheological and physiological consequences
of conversion of the maternal spiral arteries
for uteroplacental blood flow during human
pregnancy. Placenta 2009;30:473-82.
18. Redman CW, Tannetta DS, Dragovic RA,
Gardiner C, Southcombe JH, Collett GP, et
al. Review: Does size matter? Placental debris
and the pathophysiology of pre-eclampsia.
Placenta 2012;33 Suppl:S48-54.
19. Raijmakers MT, Dechend R, Poston L. Oxi-
dative stress and preeclampsia: rationale
for antioxidant clinical trials. Hypertension
2004;44:374-80.
20. Shoelson SE, Lee J, Goldfine AB. Inflam-
mation and insulin resistance. J Clin Invest
2006;116:1793-801.
21. Staff AC, Benton SJ, von Dadelszen P, Roberts
JM, Taylor RN, Powers RW, et al. Redefining
preeclampsia using placenta-derived biomar-
kers. Hypertension 2013;61:932-42.
22. Cnossen JS, ter Riet G, Mol BW, van der Post
JA, Leeflang MM, Meads CA, et al. Are tests
for predicting pre-eclampsia good enough to
make screening viable? A review of reviews
and critical appraisal. Acta Obstet Gynecol
Scand 2009;88:758-65.
23. von Dadelszen P, Magee LA, Roberts JM.
Subclassification of preeclampsia. Hypertens
Pregnancy 2003;22:143-8.
24. Powers RW, Roberts JM, Plymire DA, Pucci D,
Datwyler SA, Laird DM, et al. Low placental
growth factor across pregnancy identifies a
subset of women with preterm preeclampsia:
type 1 versus type 2 preeclampsia? Hyperten-
sion 2012;60:239-46.
